Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.110
+0.070 (3.43%)
At close: Nov 21, 2024, 4:00 PM
2.102
-0.008 (-0.39%)
After-hours: Nov 21, 2024, 5:46 PM EST
IMRX's stock price has decreased by -62.19% in the past year and price targets may not have had time to catch up.
Immuneering Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$12.80
Upside
+506.64%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Chardan Capital | Chardan Capital | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +516.11% | Nov 20, 2024 |
Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +610.90% | Nov 14, 2024 |
Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +610.90% | Sep 13, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +468.72% | Aug 7, 2024 |
Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +610.90% | Aug 7, 2024 |
Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +610.90% | May 8, 2024 |
Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +610.90% | Apr 12, 2024 |
Mizuho | Mizuho | Strong Buy Maintains $20 → $8 | Strong Buy | Maintains | $20 → $8 | +279.15% | Apr 2, 2024 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades $16 → $3 | Strong Buy → Hold | Downgrades | $16 → $3 | +42.18% | Mar 15, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $21 → $16 | Strong Buy | Maintains | $21 → $16 | +658.29% | Mar 15, 2024 |
Needham | Needham | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +610.90% | Mar 15, 2024 |
TD Cowen | TD Cowen | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 15, 2024 |
Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 14, 2024 |
Needham | Needham | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +847.87% | Mar 11, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $25 | Buy | Reiterates | $25 | +1,084.83% | Mar 5, 2024 |
Needham | Needham | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +847.87% | Mar 4, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.